Bayer Ag (adr) Stock News

Global Rapid Diagnostic Tests (RDT) Market Synopsis: The top-notch Rapid Diagnostic Tests (RDT) Market research report has been structured by skilful and experienced team players who work hard to accomplish an absolute growth and success in the business. The Marketing report

Overview of the Global Effervescent Tablet Market: An international Effervescent Tablet Market report proves to be the finest and excellent Market report as it is generated with the myriad of critical factors. To show Marketplace clearly, most up to date Market insights

Overview of Global Contraceptive Devices Market: Contraceptive Devices Market research report has been created with the systematic gathering and evaluation of Market information for Healthcare industry which is presented in a form that explains various facts and figures to the business.

Antiallergics drugs market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to grow at a CAGR of 6.90% in the above mentioned forecast period. The Antiallergics

Stefan Oelrich of German pharmaceutical firm Bayer says the company sees itself as the best owner of its three businesses — pharmaceuticals, crop science and consumer health — and there is no need

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) issued an update on its FY 2021 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of $7.660-$7.900 for the period. The company issued revenue guidance of $51.89 billion-$51.89 billion, compared to the consensus revenue estimate of $51.41 billion. Shares of BAYRY traded down $0.10 during mid-day trading []

WHIPPANY, N.J.--(BUSINESS WIRE)--The U.S. Chamber of Commerce Foundation today awarded its Annual Citizens Award in the Best Health & Wellness category to Bayer U.S. for the companys industry leading efforts with Kits4Life, a program that repurposes non-used clinical trial supplies to help people in need. The U.S. Chamber of Commerce Foundations Citizens Awards program recognizes the most innovative and impactful corporate citizenship initiatives raising the bar on social responsibility

WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer presented new analyses of data from the comprehensive Phase III finerenone clinical trial program, which analyzed KERENDIA® (finerenone) the first nonsteroidal mineralocorticoid receptor antagonist (MRA)2,3 versus placebo and in addition to standard of care on cardiovascular (CV) outcomes, including hospitalization for heart failure (HF), across a spectrum of chronic kidney disease (CKD) severity in patients with type 2 diabetes (T2D).1,4 Data from the

Industry Insights A report titled, Global Pet Insect Repellent Market Outlook 2022 has been recently published by QY Research. The dedicated analysts and researchers have carried out deep-seated research to put forth the present and future scenario of the Pet

Industry Insights A report titled, Global Pets Parasite Prevention and Control Market Outlook 2022 has been recently published by QY Research. The dedicated analysts and researchers have carried out deep-seated research to put forth the present and future scenario of

Industry Insights A report titled, Global Animals Parasite Prevention and Control Market Outlook 2022 has been recently published by QY Research. The dedicated analysts and researchers have carried out deep-seated research to put forth the present and future scenario of

Industry Insights A report titled, Global Angina Pectoris Treatment Market Outlook 2022 has been recently published by QY Research. The dedicated analysts and researchers have carried out deep-seated research to put forth the present and future scenario of the Angina

AlphaValue upgraded shares of Bayer Aktiengesellschaft (OTCMKTS:BAYRY) to a buy rating in a research note released on Monday, The Fly reports. Other equities analysts have also recently issued research reports about the company. Kepler Capital Markets reaffirmed a buy rating on shares of Bayer Aktiengesellschaft in a report on Friday, October 29th. Credit Suisse Group []

AlphaValue upgraded shares of Bayer Aktiengesellschaft (OTCMKTS:BAYRY) to a buy rating in a research report released on Monday morning, The Fly reports. Several other analysts have also weighed in on the company. JPMorgan Chase & Co. reissued an overweight rating on shares of Bayer Aktiengesellschaft in a report on Wednesday, November 10th. Morgan Stanley restated []

German drugs and pesticides maker Bayer has no plans to split its three main businesses into separately traded companies, Chief Executive Werner Baumann said, amid a flurry of conglomerates moving to